In conclusion, this study shows that fucoxanthin was more effective in MDA-MB-231 TNBC, where it can target VEGF-A and VEGF-C, inhibit cell proliferation, cell migration, and induce cell cycle arrest and apoptosis, which are cellular processes involved in breast cancer development and progression. This evidence concerns the gene VEGFC and breast carcinoma.